Cytokinetics, Incorporated (CYTK)

Cytokinetics Revenue

Cytokinetics had revenue of $1.58M in the quarter ending March 31, 2025, with 89.10% growth. This brings the company's revenue in the last twelve months to $19.22M, up 412.21% year-over-year. In the year 2024, Cytokinetics had annual revenue of $18.47M with 145.34% growth.

• Revenue (ttm): $19.22M
• Revenue Growth: +412.21%
• P/S Ratio: 204.11
• Revenue / Employee: $38,590
• Employees: 498
• Market Cap: 4.03B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.47M	10.94M	145.34%
Dec 31, 2023	7.53M	-87.06M	-92.04%
Dec 31, 2022	94.59M	24.16M	34.30%
Dec 31, 2021	70.43M	14.60M	26.15%
Dec 31, 2020	55.83M	28.96M	107.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.